Direct medical costs of cystic fibrosis in Switzerland
Description
The objective of the study is to estimate the annual direct medical costs related to the treatment of CF patients in Switzerland from a health care payer perspective using a prevalence-based bottom-up approach.
Key data
Projectlead
Project status
completed, 02/2020 - 03/2023
Institute/Centre
Winterthur Institute of Health Economics (WIG)
Funding partner
Third party
Project budget
62'000 CHF
School of Management and Law
Gertrudstrasse 8
8400 Winterthur